Evaluation of α-tubulin, detyrosinated α-tubulin, and vimentin in CTCs: identification of the interaction between CTCs and blood cells through cytoskeletal elements

Table 3 Number of circulating tumor cells per phenotype in each patient

Patients	TUB⁺VIM⁺CK⁺	TUB⁺VIM⁻CK⁺	GLU⁺VIM⁺CK⁺	GLU⁻VIM⁺CK⁺	GLU⁺VIM⁻CK⁺	GLU⁻VIM⁻CK⁺
Patients with early breast cancer
1	0	13	8	0	16	0
2	0	0	0	0	0	0
3	0	0	0	0	0	0
4	1	0	12	0	4	0
5	1	0	1	0	0	0
6	0	0	0	2	0	0
7	0	0	1	0	0	3
8	0	1	0	0	0	1
9	0	0	0	1	0	0
10	0	0	0	0	0	1
11	0	0	0	0	0	0
12	0	0	0	0	0	0
13	0	0	0	0	0	1
14	0	0	1	0	0	0
15	0	0	0	0	0	0
16	0	0	1	5	0	0
Patients with metastatic breast cancer
1	531		531	0	0	0
2	3	2	2	9	0	0
3	193	0	35	0	19	0
4	0	5	0	0	0	8
5	0	0	0	0	0	0
6	0	3	7	0	3	0
7	0	0	0	0	0	0
8	0	0	0	0	0	0
9	0	0	0	0	0	0
10	0	0	0	0	1	0
11	1	0	0	0	0	0
12	0	0	6	0	0	0
13	1	0	2	0	0	0
14	7	0	7	0	0
15	0	0	0	0	0	0
16	0	0	0	0	0	0
17	16	0	7	0	7
18	0	0	0	0	1	0
19	0	0	0	0	0	0
20	0	0	0	1	0	0
21	0	0	0	0	0	0
22	0	0	3	0	0	0
23	0	0	13	0	2	0
24	1	0	0	0	0	1

Abbreviations: CK Cytokeratin, TUB α-Tubulin, GLU Detyrosinated α-tubulin, VIM Vimentin

ISSN: 1465-542X